Myrto Boukovala

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “A candidate androgen signalling signature predictive of response to abiraterone acetate in men with metastatic castration-resistant prostate cancer”.

A candidate androgen signalling signature predictive of response to abiraterone acetate in men with metastatic castration-resistant prostate cancer

European Journal of Cancer(2020)10.1016/j.ejca.2019.12.027

N/A

0.435DataRank · unranked

7 citations

Nicholas Spetsieris, Justin A. Weldon, Alexandros Tsikkinis, Anh Hoang, Ana M. Aparicio +14 more

A Phase 2 Trial of Abiraterone Followed by Randomization to Addition of Dasatinib or Sunitinib in Men With Metastatic Castration-Resistant Prostate Cancer

Clinical Genitourinary Cancer(2020)10.1016/j.clgc.2020.05.013

N/A

0DataRank · unranked

16 citations

Myrto Boukovala, Justin A. Weldon, Alexandros Tsikkinis, Anh Hoang, Ana M. Aparicio +15 more

Neoadjuvant apalutamide (APA) plus leuprolide (LHRHa) with or without abiraterone (AA) in localized high-risk prostate cancer (LHRPC).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.5504

N/A

0DataRank · unranked

18 citations

Myrto Boukovala, Nicholas Spetsieris, Sijin Wen, Anh Hoang, Justin A. Weldon +15 more